Skip to content

kustumbaru kalka and tab doxinate effect in garbhini chardi

A RANDOMISED CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF KUSTUMBARU KALKA IN GARBHINI CHARDI WITH SPECIAL REFERENCE TO EMESIS GRAVIDARUM - Nil

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100969
Enrollment
80
Registered
2026-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS- Health Condition 2: PCS-

Interventions

None listed

Sponsors

DR VAISHALI RAVSAHEB BAVISKAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 pregnant females diagnosed with garbhini chardi in first trimester of pregnancy of any gravida 2 anc profile already done by patients

Exclusion criteria

Exclusion criteria: 1 Hyperemesis gravidaraum 2 Pregnant women suffering from severe infections such as TORCH etc. 3 Pregnant women suffering from systemic disorders such as DM HTN THYROID 4 Pregnant women on other medications such as antifungal,antibiotics

Design outcomes

Primary

MeasureTime frame
To evaluate and compare the efficacy of kustumbaru kalka and tab doxinate in garbhini chardi w.s.r.t emesis gravidaramTimepoint: 1st visit - day 0 2nd visit - day 3 3rd visit - day 7 4th visit - day 15

Secondary

MeasureTime frame
To put forth the effective,safe & easily available management of garbhini chardiTimepoint: 1st visit - day 0 2nd visit - day 3 3rd visit - day 7 4th visit - day 15

Countries

India

Contacts

Public ContactDr Seema Mehere

Dr G D Pol Foundation YMT Ayurvedic medical college , Kharghar , Navi Mumbai

seema.mehre@mail.com9930940403

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026